Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 4:15 pm Purchase |
2025-04-09 | 13G | 180 Life Sciences Corp. ATNF |
Amtrust Financial Services Inc. AFSI |
509,707 9.800% |
509,707 (New Position) |
Filing History |
| 2025-04-11 6:05 pm Purchase |
2025-03-27 | 13D | 180 Life Sciences Corp. ATNF |
ELRAY RESOURCES INC. ELRA |
4,318,000 52.800% |
4,318,000 (New Position) |
Filing History |
| 2025-02-25 5:35 pm Purchase |
2025-02-20 | 13D | 180 Life Sciences Corp. ATNF |
Jordan Blair | 403,166 10.500% |
403,166 (New Position) |
Filing History |
| 2025-02-14 6:36 pm Purchase |
2024-12-31 | 13G | 180 Life Sciences Corp. ATNF |
Anson Funds Management LP | 225,271 7.100% |
225,271 (New Position) |
Filing History |
| 2025-02-13 1:01 pm Purchase |
2024-12-31 | 13G | 180 Life Sciences Corp. ATNF |
Ayrton Capital LLC | 334,742 9.900% |
334,742 (New Position) |
Filing History |
| 2025-01-10 5:00 pm Purchase |
2024-12-27 | 13D | 180 Life Sciences Corp. ATNF |
Anthony Brian Goodman | 4,318,000 57.600% |
4,318,000 (New Position) |
Filing History |
| 2025-01-03 8:08 pm Purchase |
2024-12-27 | 13G | 180 Life Sciences Corp. ATNF |
Mitchell P. Kopin | 165,293 4.990% |
165,293 (New Position) |
Filing History |
| 2024-11-14 3:53 pm Purchase |
2024-09-30 | 13G | 180 Life Sciences Corp. ATNF |
Armistice Capital, LLC | 53,935 4.990% |
53,935 (New Position) |
Filing History |
| 2024-10-18 5:00 pm Purchase |
2024-09-05 | 13G | 180 Life Sciences Corp. ATNF |
Feldmann Marc | 90,532 8.600% |
83,072 (+1113.51%) |
Filing History |
| 2024-02-14 3:27 pm Purchase |
2023-12-31 | 13G | 180 Life Sciences Corp. ATNF |
Armistice Capital, LLC | 58,552 9.990% |
58,552 (New Position) |
Filing History |
| 2023-04-14 5:00 pm Purchase |
2022-12-23 | 13D | 180 Life Sciences Corp. ATNF |
Feldmann Marc | 7,460 3.400% |
7,460 (New Position) |
Filing History |
| 2022-02-09 3:15 pm Sale |
2021-12-31 | 13G | 180 Life Sciences Corp. ATNF |
The Vanguard Group | 2,643 2.950% |
-461 (-14.85%) |
Filing History |
| 2022-02-09 3:15 pm Sale |
2021-12-31 | 13G | 180 Life Sciences Corp. ATNF |
VANGUARD INDEX FUNDS | 2,643 2.950% |
-171 (-6.08%) |
Filing History |
| 2022-02-07 4:30 pm Purchase |
2021-12-31 | 13G | 180 Life Sciences Corp. ATNF |
Nanchahal Jagdeep | 4,001 4.500% |
526 (+15.14%) |
Filing History |
| 2021-12-13 4:21 pm Purchase |
2021-12-08 | 13D | 180 Life Sciences Corp. ATNF |
Feldmann Marc | 7,460 8.200% |
627 (+9.17%) |
Filing History |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | 180 Life Sciences Corp. ATNF |
The Vanguard Group | 3,104 6.540% |
3,104 (New Position) |
Filing History |
| 2021-02-08 10:37 am Purchase |
2020-12-31 | 13G | 180 Life Sciences Corp. ATNF |
VANGUARD INDEX FUNDS | 2,814 5.930% |
2,814 (New Position) |
Filing History |
| 2020-12-31 2:32 pm Purchase |
2020-11-06 | 13G | 180 Life Sciences Corp. ATNF |
BAUER RONALD J | 6,000 9.200% |
6,000 (New Position) |
Filing History |
| 2020-12-30 5:00 pm Sale |
2020-12-16 | 13D | 180 Life Sciences Corp. ATNF |
KBL IV SPONSOR LLC | 6,637 10.250% |
-1,058 (-13.75%) |
Filing History |
| 2020-12-29 1:22 pm Purchase |
2020-11-06 | 13G | 180 Life Sciences Corp. ATNF |
BRIDGMAN CRAIG | 4,615 11.000% |
4,615 (New Position) |
Filing History |